Cargando…

Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines

Neuroblastoma (NB) is a heterogenous disease with treatment varying from observation for low-risk tumors, to extensive therapy with chemotherapy, surgery, radiotherapy, and autologous bone-marrow-transplantation and immunotherapy. However, a high frequency of primary-chemo-refractory disease and rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holzhauser, Stefan, Lukoseviciute, Monika, Papachristofi, Christina, Vasilopoulou, Christina, Herold, Nikolas, Wickström, Malin, Kostopoulou, Ourania N., Dalianis, Tina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864013/ https://www.ncbi.nlm.nih.gov/pubmed/33491755 http://dx.doi.org/10.3892/ijo.2021.5167

Ejemplares similares

Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines
por: Lukoseviciute, Monika, et al.
Publicado: (2021)

Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines
por: Lukoseviciute, Monika, et al.
Publicado: (2023)

Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors
por: Kostopoulou, Ourania N., et al.
Publicado: (2022)

Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma
por: Lukoseviciute, Monika, et al.
Publicado: (2023)

Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
por: Byskata, Karin, et al.
Publicado: (2022)

Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
por: Holzhauser, Stefan, et al.
Publicado: (2021)

Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
por: Näsman, Anders, et al.
Publicado: (2021)

High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
por: de Flon, Caroline Haglund, et al.
Publicado: (2023)

Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines
por: Ödborn Jönsson, Linnéa, et al.
Publicado: (2021)

Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
por: Johnsen, John Inge, et al.
Publicado: (2019)

Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
por: Khalil, Mohamed Ashraf, et al.
Publicado: (2016)

FGFR1 is a potential therapeutic target in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2022)

Whole-Exome Sequencing of HPV Positive Tonsillar and Base of Tongue Squamous Cell Carcinomas Reveals a Global Mutational Pattern along with Relapse-Specific Somatic Variants
por: Ährlund-Richter, Andreas, et al.
Publicado: (2021)

BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
por: Krämer, Katja F., et al.
Publicado: (2017)

Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells
por: Merlos Rodrigo, Miguel Angel, et al.
Publicado: (2021)

DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas
por: Giraud, Géraldine, et al.
Publicado: (2009)

Aqueous fish extract increases survival in the mouse model of cytostatic toxicity
por: Omerovic, Elmir, et al.
Publicado: (2008)

The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma
por: Sorteberg, Agnes Luise, et al.
Publicado: (2022)

Intrathecal Chemotherapy: Selection of Cytostatic Agents
por: Hayakawa, T., et al.
Publicado: (1970)

The cytostatic activity of cultured Kupffer cells.
por: Pulford, K., et al.
Publicado: (1985)

Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features
por: Zupancic, Mark, et al.
Publicado: (2022)

SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
por: Tümmler, Conny, et al.
Publicado: (2019)

The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling
por: Diao, Yumei, et al.
Publicado: (2014)

Signaling Mechanisms that Suppress the Cytostatic Actions of Rapamycin
por: Jahn, Stephan C., et al.
Publicado: (2014)

Optimisation of maintenance in delivery systems for cytostatic medicines
por: Carnero, María Carmen, et al.
Publicado: (2021)

Cytostatics in Indoor Environment: An Update of Analytical Methods
por: Portilha-Cunha, M. Francisca, et al.
Publicado: (2021)

Cytostatic hypothermia and its impact on glioblastoma and survival
por: Enam, Syed Faaiz, et al.
Publicado: (2022)

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
por: Dyberg, Cecilia, et al.
Publicado: (2016)

UHPLC-HRMS data from non-targeted screening for biotransformation products of cytostatic drug imatinib
por: Tkalec, Žiga, et al.
Publicado: (2022)

The Cytostatic Action of Extracellular NAD in Tumour-bearing Mice
por: Nolde, Siegmar, et al.
Publicado: (1972)

Intraperitoneal cytostatics impair healing of experimental intestinal anastomoses.
por: de Roy van Zuidewijn, D. B., et al.
Publicado: (1991)

The toxic effect of cytostatics on primary cilia frequency and multiciliation
por: Filipová, Alžběta, et al.
Publicado: (2019)

Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents
por: Petroni, Giulia, et al.
Publicado: (2021)

Therapeutic potentials and challenges of cytostatic persister cancer cells
por: Kim, Paul Y., et al.
Publicado: (2023)

Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
por: Tasaka, Keiji, et al.
Publicado: (2022)

Neuroblastoma in childhood: review and radiological findings
por: Papaioannou, Georgia, et al.
Publicado: (2005)

Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3
por: Bersani, Cinzia, et al.
Publicado: (2017)

Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications.
por: SÃ¸rensen, J. B., et al.
Publicado: (1989)

Enhanced cytostatic activity of the sesquiterpene lactone eupatoriopicrin by glutathione depletion.
por: Woerdenbag, H. J., et al.
Publicado: (1989)

Cytostatic drug treatment causes seeding of gene promoter methylation
por: Bredberg, Anders, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_pttvlj2g290egdrgrqfku934vo